{"id":"https://openalex.org/W2017173005","doi":"https://doi.org/10.2174/157489106775244082","title":"Patented HIV-1 Integrase Inhibitors (1998-2005)","display_name":"Patented HIV-1 Integrase Inhibitors (1998-2005)","alternate_titles":[],"publication_year":2006,"publication_date":"2006-01-01","ids":{"openalex":"https://openalex.org/W2017173005","doi":"https://doi.org/10.2174/157489106775244082","mag":"2017173005","pmid":"https://pubmed.ncbi.nlm.nih.gov/18221130"},"language":"en","primary_location":{"id":"doi:10.2174/157489106775244082","doi":"https://doi.org/10.2174/157489106775244082","is_oa":false,"landing_page_url":"https://doi.org/10.2174/157489106775244082","pdf_url":null,"source":{"id":"https://openalex.org/S117972718","display_name":"Recent Patents on Anti-Infective Drug Discovery","issn_l":"1574-891X","issn":["1574-891X","2212-4071"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-40"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Recent Patents on Anti-Infective Drug Discovery","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2017173005"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017363924","display_name":"Philippe Cotelle","orcid":"https://orcid.org/0000-0003-0924-0433","observed_orcids":["https://orcid.org/0000-0003-0924-0433"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Philippe Cotelle","raw_affiliation_strings":["Laboratoire de ChimieOrganique et Macromoleculaire, UMR CNRS 8009, Universite de Lille 1,59655 Villeneuve d'Ascq, France;",",France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de ChimieOrganique et Macromoleculaire, UMR CNRS 8009, Universite de Lille 1,59655 Villeneuve d'Ascq, France;","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I2279609970"]},{"raw_affiliation_string":",France","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5017363924"],"corresponding_institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I2279609970"],"apc_list":null,"apc_paid":null,"fwci":5.4326,"has_fulltext":false,"cited_by_count":53,"citation_normalized_percentile":{"value":0.95921779,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"1","issue":"1","first_page":"1","last_page":"15"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1-integrase-inhibitors","display_name":"HIV-1 integrase inhibitors","score":0.9990000128746033},{"id":"https://openalex.org/keywords/patents","display_name":"patents","score":0.6779999732971191},{"id":"https://openalex.org/keywords/small-molecule-inhibitors","display_name":"small molecule inhibitors","score":0.6330000162124634},{"id":"https://openalex.org/keywords/integrase-strand-transfer-inhibitors","display_name":"integrase strand transfer inhibitors","score":0.9160000085830688},{"id":"https://openalex.org/keywords/highly-active-antiretroviral-therapy","display_name":"highly active antiretroviral therapy","score":0.8809999823570251},{"id":"https://openalex.org/keywords/hiv-replication","display_name":"HIV replication","score":0.5180000066757202},{"id":"https://openalex.org/keywords/integrase-inhibitors","display_name":"integrase inhibitors","score":0.5730000138282776},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5929999947547913},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.44699999690055847}],"concepts":[{"id":"https://openalex.org/C14430832","wikidata":"https://www.wikidata.org/wiki/Q412550","display_name":"Integrase","level":3,"score":0.9407040476799011},{"id":"https://openalex.org/C2777302000","wikidata":"https://www.wikidata.org/wiki/Q412251","display_name":"Integrase inhibitor","level":5,"score":0.632132887840271},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.6049485206604004},{"id":"https://openalex.org/C2779502633","wikidata":"https://www.wikidata.org/wiki/Q937224","display_name":"Dolutegravir","level":5,"score":0.5315707921981812},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.5257090926170349},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5215263962745667},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5018014907836914},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4817802608013153},{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.47445735335350037},{"id":"https://openalex.org/C140704245","wikidata":"https://www.wikidata.org/wiki/Q3933202","display_name":"Viral replication","level":3,"score":0.462763249874115},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.41921648383140564},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40936028957366943},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3627619743347168},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3441413938999176},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3239558935165405},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.31868577003479004},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.23675531148910522},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.23068055510520935},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.12751296162605286},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.10077330470085144},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010330","descriptor_name":"Patents as Topic","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014486","descriptor_name":"United States Food and Drug Administration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019427","descriptor_name":"HIV Integrase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019427","descriptor_name":"HIV Integrase","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D019428","descriptor_name":"HIV Integrase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019428","descriptor_name":"HIV Integrase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2174/157489106775244082","doi":"https://doi.org/10.2174/157489106775244082","is_oa":false,"landing_page_url":"https://doi.org/10.2174/157489106775244082","pdf_url":null,"source":{"id":"https://openalex.org/S117972718","display_name":"Recent Patents on Anti-Infective Drug Discovery","issn_l":"1574-891X","issn":["1574-891X","2212-4071"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-40"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Recent Patents on Anti-Infective Drug Discovery","raw_type":"journal-article"},{"id":"pmid:18221130","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18221130","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Recent patents on anti-infective drug discovery","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307875","display_name":"Styrelsen f\u00f6r Internationellt Utvecklingssamarbete","ror":"https://ror.org/01fn7me06"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W50335808","https://openalex.org/W180725227","https://openalex.org/W1600632000","https://openalex.org/W1851303894","https://openalex.org/W1939718347","https://openalex.org/W1970850106","https://openalex.org/W1972342674","https://openalex.org/W1975940894","https://openalex.org/W1983644993","https://openalex.org/W1993251454","https://openalex.org/W2001243226","https://openalex.org/W2005663970","https://openalex.org/W2014711863","https://openalex.org/W2021944591","https://openalex.org/W2029546022","https://openalex.org/W2032891258","https://openalex.org/W2035914286","https://openalex.org/W2041514872","https://openalex.org/W2050310420","https://openalex.org/W2053577250","https://openalex.org/W2064645523","https://openalex.org/W2065208435","https://openalex.org/W2067663373","https://openalex.org/W2067786897","https://openalex.org/W2067862286","https://openalex.org/W2071179774","https://openalex.org/W2073565105","https://openalex.org/W2076634735","https://openalex.org/W2085133713","https://openalex.org/W2087400133","https://openalex.org/W2089440631","https://openalex.org/W2089660336","https://openalex.org/W2096404755","https://openalex.org/W2108841553","https://openalex.org/W2108931144","https://openalex.org/W2111313968","https://openalex.org/W2113428012","https://openalex.org/W2116889230","https://openalex.org/W2123529547","https://openalex.org/W2127484412","https://openalex.org/W2142492769","https://openalex.org/W2143374044","https://openalex.org/W2150655989","https://openalex.org/W2160982073","https://openalex.org/W2165130939","https://openalex.org/W2165577691","https://openalex.org/W2171711893","https://openalex.org/W2334864457","https://openalex.org/W2413846099"],"related_works":["https://openalex.org/W2021944591","https://openalex.org/W1987390030","https://openalex.org/W2008041994","https://openalex.org/W2029312905","https://openalex.org/W2038196376","https://openalex.org/W2415220475","https://openalex.org/W2023632245","https://openalex.org/W1833342122","https://openalex.org/W1981989716","https://openalex.org/W2143374044"],"abstract_inverted_index":{"Combination":[0],"therapy,":[1],"comprising":[2],"at":[3],"least":[4],"three":[5,127],"anti-human":[6],"immunodeficiency":[7],"virus":[8],"(anti-HIV)":[9],"drugs,":[10],"has":[11,33,51,130],"become":[12],"the":[13,88,96,126,154,166,170,180,184],"standard":[14],"treatment":[15],"of":[16,43,61,125,157,174],"AIDS.":[17],"Since":[18],"1996,":[19],"highly":[20],"active":[21],"antiretroviral":[22],"therapy":[23],"(HAART)":[24],"was":[25],"designed":[26],"to":[27,76,87,179],"rapidly":[28,132],"control":[29],"HIV":[30,97],"replication.":[31],"It":[32],"had":[34],"a":[35,118,135],"significant":[36],"impact":[37],"on":[38,159],"patient":[39,62],"health":[40],"and":[41,68,92,121],"progression":[42],"AIDS":[44],"in":[45,147,165],"developed":[46],"countries":[47],"but":[48],"its":[49],"success":[50],"not":[52],"been":[53,131],"complete.":[54],"HAART":[55],"strategy":[56],"still":[57],"suffers":[58],"from":[59,169],"issues":[60],"compliance,":[63],"cost,":[64],"deleterious":[65],"side":[66],"effects":[67],"emerging":[69],"drug":[70],"resistance.":[71],"Therefore":[72],"it":[73],"is":[74,117],"logical":[75],"look":[77],"for":[78,111,138],"agents":[79],"that":[80,104],"inhibit":[81],"different":[82],"viral":[83,128],"targets.":[84],"In":[85],"addition":[86],"fusion,":[89],"reverse":[90],"transcription":[91],"protein":[93],"formation":[94],"processes,":[95],"replicative":[98],"cycle":[99],"offers":[100],"various":[101],"other":[102],"events":[103],"can":[105],"be":[106],"considered":[107],"as":[108,134],"potential":[109],"targets":[110],"chemotherapeutic":[112],"intervention.":[113],"Amongst":[114],"them":[115],"integration":[116],"key":[119],"step":[120],"integrase":[122,163],"(IN),":[123],"one":[124],"enzymes,":[129],"identified":[133],"rational":[136],"target":[137],"many":[139],"years.":[140],"To":[141],"date,":[142],"four":[143],"molecules":[144,186],"have":[145],"entered":[146],"clinical":[148,188],"trials.":[149,189],"The":[150],"present":[151],"article":[152],"reviews":[153],"increasing":[155],"number":[156],"patents":[158,182],"small":[160],"molecule":[161],"HIV-1":[162],"inhibitors":[164],"1998-2005":[167],"period,":[168],"pioneer":[171],"ones":[172],"(discovery":[173],"selective":[175],"strand":[176],"transfer":[177],"inhibitors)":[178],"last":[181],"including":[183],"actual":[185],"under":[187]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2017173005","counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
